The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.
University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice
Professor Gary Maartens is both head of clinical pharmacology at the University of Cape Town (UCT) and a chief specialist physician at Groote Schuur Hospital. Earlier this year, South Africa’s National Research Foundation (NRF) recognised his contribution to the field by awarding him an A rating.
A breakthrough study conducted by Professor Keertan Dheda and Dr Michele Tomasicchio, at the University of Cape Town’s (UCT) Centre for Lung Infection and Immunity, has revealed that one of South Africa’s most commonly-used injectable contraceptives could potentially increase women’s chances of contracting tuberculosis (TB).
In 2015, Dr Nadia Ikumi (née Chanzu) - a young Kenyan scientisty - became the first African to be awarded a postdoctoral fellowship by the AXA Research Fund. A researchers at the Institure of Infectious Disease and Molecular Medicine at the University of Cape Town (UCT), Ikumi aims to understand the influence of the HIV infection on the immune system of pregnant women and their unborn children.
Established in 2001, the South African Tuberculosis Vaccine Initiative (SATVI) was presented with the University of Cape Town's (UCT) 2018 Social Responsiveness Award at the Faculty of Health Sciences graduations ceremony on Saturday, 13 April.
